Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transport protein 2C is an integral membrane transporter responsible for the reabsorption of inorganic phosphate in the kidney via sodium-coupled transport. It regulates local and systemic phosphate concentrations, supporting bone health, cellular metabolism, and energy production. Dysfunction or genetic mutations in this transporter (SLC34A3 gene) cause hereditary hypophosphatemic rickets with hypercalciuria, marked by phosphate wasting, rickets, and increased vitamin D levels. The protein is a member of the SLC34 family and primarily expressed in the renal proximal tubule, mediating 2 Na+:1 phosphate ion exchange. Its activity is fundamental for maintaining balance of phosphate and overall mineral metabolism
Drugs or small molecules targeting Sodium-dependent phosphate transport protein 2C would exert action by modulating renal phosphate reabsorption (typically by inhibiting or enhancing transporter activity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transport protein 2C (SLC34A3).